Guangdong Key Laboratory of Nanomedicine, CAS-HK Joint Lab for Biomaterials, Shenzhen Engineering Laboratory of Nanomedicine and Nanoformulations, Institute of Biomedicine and Biotechnology, Shenzhen Institutes of Advanced Technology (SIAT), Chinese Academy of Sciences, Shenzhen, 518055, PR China.
Guangdong Key Laboratory of Nanomedicine, CAS-HK Joint Lab for Biomaterials, Shenzhen Engineering Laboratory of Nanomedicine and Nanoformulations, Institute of Biomedicine and Biotechnology, Shenzhen Institutes of Advanced Technology (SIAT), Chinese Academy of Sciences, Shenzhen, 518055, PR China; University of Chinese Academy of Sciences, Beijing, 100049, PR China.
Acta Biomater. 2020 Mar 1;104:188-197. doi: 10.1016/j.actbio.2020.01.012. Epub 2020 Jan 13.
Advanced colorectal cancer has a high mortality rate since conventional treatments have limited therapeutic effects and poor prognosis with high risks of metastasis and recurrence. Photodynamic therapy (PDT) is a promising treatment modality for the eradication of colorectal cancer, but its curative efficacy is severely affected by tumor hypoxia. Herein, we developed a core-shell gold nanocage coated with manganese dioxide and hyaluronic acid (AMH) for targeted delivery to colorectal tumors and oxygenation-boosted immunogenic phototherapy in situ. The AMH nanoparticles can generate abundant oxygen from mild acidic/HO medium, which can further enhance the PDT efficacy of AMH itself under near infrared (NIR) irradiation. Meanwhile, AMH-based PDT induced immunogenic cell death (ICD) of tumor cells with damage-associated molecular patterns (DAMPs) release and facilitated the dendritic cells (DCs) maturation to further potentiate the systematic antitumor immunity against advanced tumors. In vivo experiment results exhibited that AMH nanoparticles not only had the ability of targeting tumor but also in situ produced sufficient oxygen to relieve the tumor hypoxia. Furthermore, AMH-mediated oxygen-boosted immunogenic PDT effectively inhibited the tumor growth and recurrence. Thus, this work provides a potent targeted delivery nanoplatform for enhanced immunogenic PDT against advanced cancers. STATEMENT OF SIGNIFICANCE: Local hypoxic tumor microenvironment not only greatly limits the photodynamic therapy (PDT) efficacy, but also has an association with tumor invasiveness and metastasis. This study provides an AMH nanoparticle for targeted delivery to colorectal tumors and oxygenation-boosted immunogenic PDT in situ. AMH nanoparticle exhibits a good tumor-targeted ability to in situ produce abundant oxygen to relieve the tumor hypoxia, and initiates the potent oxygen-boosted immunogenic PDT effect under NIR irradiation to effectively inhibit the growth and recurrence of colorectal tumor. This oxygen-boosted immunogenic PDT nanosystem can be a promising candidate for advanced tumor treatment.
晚期结直肠癌的死亡率很高,因为传统治疗方法的治疗效果有限,预后较差,转移和复发的风险很高。光动力疗法(PDT)是一种很有前途的结直肠癌治疗方法,但它的疗效受到肿瘤缺氧的严重影响。在此,我们开发了一种核壳结构的金纳米笼,其表面包覆有二氧化锰和透明质酸(AMH),可用于结直肠肿瘤的靶向递药和原位氧增强免疫原性光疗。AMH 纳米颗粒可以从温和的酸性/HO 介质中产生丰富的氧气,在近红外(NIR)照射下,进一步增强 AMH 本身的 PDT 疗效。同时,基于 AMH 的 PDT 诱导肿瘤细胞发生免疫原性细胞死亡(ICD),释放损伤相关分子模式(DAMPs),并促进树突状细胞(DCs)成熟,从而进一步增强对晚期肿瘤的系统抗肿瘤免疫。体内实验结果表明,AMH 纳米颗粒不仅具有靶向肿瘤的能力,而且还能原位产生足够的氧气来缓解肿瘤缺氧。此外,AMH 介导的氧增强免疫原性 PDT 有效地抑制了肿瘤的生长和复发。因此,这项工作为增强免疫原性 PDT 治疗晚期癌症提供了一种有效的靶向递药纳米平台。
局部缺氧肿瘤微环境不仅极大地限制了光动力疗法(PDT)的疗效,而且与肿瘤的侵袭性和转移有关。本研究提供了一种 AMH 纳米颗粒,用于结直肠肿瘤的靶向递药和原位氧增强免疫原性 PDT。AMH 纳米颗粒具有良好的肿瘤靶向能力,可原位产生丰富的氧气来缓解肿瘤缺氧,并在 NIR 照射下引发有效的氧增强免疫原性 PDT 效应,从而有效抑制结直肠肿瘤的生长和复发。这种氧增强免疫原性 PDT 纳米系统有望成为治疗晚期肿瘤的一种有前途的候选药物。